Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative - Fierce Pharma
Fierce Pharma reports on Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative in Science & Health.
news.takeacoffee.club
Latest headlines and source-linked updates from the Science & Health desk.
Fierce Pharma reports on Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative in Science & Health.
medpagetoday.com reports on FDA's 'Big Dick Energy!' Warning; UHC Retreats on Prior Auth; Nurses Beat Ebola in Science & Health.
HDFC Sky reports on Wockhardt Shares Surge 16% on US FDA Drug Approval in Science & Health.
pharmiweb.com reports on Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Pove in Science & Health.
The Economic Times reports on FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market in Science & Health.
Science & Health
Crain's Chicago Business reports on Tempus AI scores key FDA approval ahead of cancer confab in Science & Health.
Investing.com reports on Imfinzi receives FDA approval for early bladder cancer treatment in US in Science & Health.
The Manila Times reports on China's Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA in Science & Health.
TradingView reports on Shionogi Co Ltd - Shionogi's U.S. Unit Receives FDA Approval For Ensitrelvir As Post-Exposure Prophylaxis For Covid-19 in Science & Health.
NDTV Profit reports on US FDA Approval For Zaynich Puts Wockhardt's Innovation Bet To The Test in Science & Health.
The Economic Times reports on Wockhardt shares in focus after FDA approval for antibiotic targeting drug-resistant infections. Check det in Science & Health.
Fierce Pharma reports on MannKind seeks long-awaited sales boost with inhaled insulin approval for kids in Science & Health.
Cardiovascular Business reports on FDA shares another warning about Impella heart pumps after death in Science & Health.
Stock Titan reports on FDA approves first inhaled mealtime insulin for kids 6+ in Science & Health.
Top stories across the U.S., delivered every morning.